EIF3A and neoplasm: The small molecule NCE22 has demonstrated cytotoxicity against tumor cells in vitro by acting as an inhibitor of eIF3a.227 Ongoing studies are currently investigating the potential clinical applications and benefits of eIF3 subunits for patients.